Vaccine News and Research

Latest Vaccine News and Research

With 7.7M child deaths expected this year, study finds global child deaths falling faster than expected

With 7.7M child deaths expected this year, study finds global child deaths falling faster than expected

WHA endorses interim targets to eradicate measles as WHO warns disease on the rise

WHA endorses interim targets to eradicate measles as WHO warns disease on the rise

Joint research by UB and CDC could lead to new generation of antiviral medicines

Joint research by UB and CDC could lead to new generation of antiviral medicines

Scientists develop DNA-vaccine that restricts supply of blood to tumours

Scientists develop DNA-vaccine that restricts supply of blood to tumours

Majority parents feel they should decide on vaccination for their children, not the government : Harris Interactive poll

Majority parents feel they should decide on vaccination for their children, not the government : Harris Interactive poll

Delegates at the World Health Assembly adopt resolutions on variety of global health issues

Delegates at the World Health Assembly adopt resolutions on variety of global health issues

WHA passes a new resolution to combat childhood pneumonia

WHA passes a new resolution to combat childhood pneumonia

Researchers test NicVAX vaccine to help people quit smoking, avoid relapses

Researchers test NicVAX vaccine to help people quit smoking, avoid relapses

New England Peptide launches NEPTune line of custom proteomics reagents

New England Peptide launches NEPTune line of custom proteomics reagents

ImmunoCellular Therapeutics to present clinical results of ICT-107 dendritic cell immunotherapy at 46th ASCO

ImmunoCellular Therapeutics to present clinical results of ICT-107 dendritic cell immunotherapy at 46th ASCO

New data highlighting Pfizer's approach to cancer drug development to be presented at ASCO meeting

New data highlighting Pfizer's approach to cancer drug development to be presented at ASCO meeting

Sorrento Therapeutics receives STTR grant to develop antibody therapeutics to combat MRSA

Sorrento Therapeutics receives STTR grant to develop antibody therapeutics to combat MRSA

Results of BioSante's 2A/Furin technology in industrial antibody CHO expression system announced

Results of BioSante's 2A/Furin technology in industrial antibody CHO expression system announced

Clinical Infectious Diseases journal examines new scientific advances to curb HIV, TB epidemics

Clinical Infectious Diseases journal examines new scientific advances to curb HIV, TB epidemics

JCVI researchers construct first self-replicating, synthetic bacterial cell

JCVI researchers construct first self-replicating, synthetic bacterial cell

British Columbia first in Canada to include Prevnar 13 in routine child immunization program

British Columbia first in Canada to include Prevnar 13 in routine child immunization program

Hendra virus infects a horse in south Queensland – authorities fear spread

Hendra virus infects a horse in south Queensland – authorities fear spread

GeoVax Labs spotlighted on interactive map posted on the website of Inc. magazine

GeoVax Labs spotlighted on interactive map posted on the website of Inc. magazine

Phase 1/2 clinical trial data of Oncophage for recurrent high-grade glioma

Phase 1/2 clinical trial data of Oncophage for recurrent high-grade glioma

Research and movement in future towards universal influenza virus vaccine

Research and movement in future towards universal influenza virus vaccine

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.